Skip to main content
. 2019 Dec 19;3(24):4202–4214. doi: 10.1182/bloodadvances.2019000702

Figure 4.

Figure 4.

1q21 amplification correlates with increased MCL-1i sensitivity. (A) Differences in specific apoptosis of patients with wild-type (WT) 1q21 (n = 32) or amplification of 1q21 (n = 12), after treatment with MCL-1i for 24 hours. (B) Differences in specific apoptosis of patients with WT and amplified 1q21 after treatment with BCL-2i (left) or BCL-XLi (right) and their combinations with MCL-1i (all inhibitors, 100 nM). ns, nonsignificant.